RNF43 p.G659fs 通过 PI3K/AKT/mTOR 信号通路和 HLA-E 上调导致 MSI-high 结直肠癌中 NK 细胞功能障碍
RNF43 p.G659fs leads to natural killer cell dysfunction in MSI-high colorectal cancer through PI3K/AKT/mTOR signaling and HLA-E up-regulation.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:TLR-mediated calcium signaling regulates killing capacity of expanded NK cells: challenges for potential AML immunotherapy.
TLR-mediated calcium signaling regulates killing capacity of expanded NK cells: challenges for potential AML immunotherapy.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
自然杀伤(NK)细胞是癌症免疫监视和免疫治疗的核心。其杀伤能力对于高效清除靶细胞至关重要,并依赖于严格调控的 Ca2+ 信号来控制颗粒酶脱颗粒。Toll 样受体(TLR)的参与在其他免疫细胞类型中已被证实与 Ca2+ 信号相关,但其在 NK 细胞中的具体作用仍未明确。鉴于 NK 细胞表达广泛的 TLR,且 TLR 配体——包括损伤相关和病原体相关分子模式——的存在可影响包括过继性 NK 细胞治疗在内的临床场景,研究 TLR 驱动的 Ca2+ 信号在 NK 细胞中的作用尤为重要。
在此,我们研究了用选定的 TLR 配体刺激如何影响 Ca2+ 信号和 NK 细胞活性。即时刺激诱导扩增 NK 细胞中胞质 Ca2+ 的快速升高。在功能上,TLR 刺激增加了脱颗粒,并在高效靶比下增强了细胞毒性。
然而,在靶细胞过量的条件下,TLR 处理的 NK 细胞表现出杀伤能力受损,可能是由于 Ca2+ 水平失衡所致。这些发现表明,TLR 信号直接调节 NK 细胞中的 Ca2+ 流,并可根据具体情况增强或损害细胞毒性活性。尽管临床意义仍属假设,但这种 TLR 驱动的失调会影响在化疗后经常遇到的炎症或病原体富集环境中的 NK 细胞杀伤活性。
我们的发现提示,在过继转移治疗中应考虑 TLR-Ca2+ 对细胞毒性的影响,尤其是在既往治疗影响全身 TLR 配体水平的患者中,例如急性髓系白血病患者,NK 细胞免疫治疗常在此类患者中进行试验。
Natural killer (NK) cells are central to cancer immunosurveillance and immunotherapy. Their ability to engage in killing is critical for efficient target elimination and depends on tightly regulated Ca2+ signaling controlling granzyme degranulation. Toll-like receptor (TLR) engagement has been linked to Ca2+ signaling in other immune cell types, while a specific role in NK cells remains unresolved.
Given that NK cells express a broad range of TLRs, and that presence of TLR ligands-including damage- and pathogen-associated molecular patterns-can influence clinical scenarios including adoptive NK cell therapy, investigating TLR-driven Ca2+ signaling in NK cells is particularly relevant.
Here, we examined how stimulation with selected TLR ligands influences Ca2+ signaling and NK cell activity. Immediate stimulation induced a rapid elevation of cytosolic Ca2+ in expanded NK cells. Functionally, TLR stimulation increased degranulation and enhanced cytotoxicity at high effector-to-target ratios. Under conditions of target excess, however, TLR-treated NK cells displayed impaired killing, likely due to unbalanced Ca2+ levels.
These findings demonstrate that TLR signaling directly modulates Ca2+ flux in NK cells and can either potentiate or impair cytotoxic activity depending on context. Although clinical implications remain hypothetical, such TLR-driven dysregulation affects NK cell killing activity in the inflammatory or pathogen-rich environments frequently encountered after chemotherapy.
Our findings suggest that TLR-Ca2+ impact on cytotoxicity should be considered in adoptive transfer therapies where previous treatment affects systemic levels of TLR ligands, such as in patients with acute myeloid leukemia, where NK cell immunotherapy is frequently tested in trials.
MEMBER ACCOUNT
登录成功会直接打开下一页。